| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.05. | GSK announces bepirovirsen's 'functional cure' data to treat chronic hepatitis B | ||
| 29.05. | The blind spot undermining pharma product launches - and how to eliminate it | ||
| 29.05. | Delphia Therapeutics appoints David Kerstein as Chief Medical Officer | ||
| 28.05. | Why HCP AI use is now a brand strategy opportunity for pharma | ||
| 28.05. | NICE recommends Genmab's Tivdak for recurrent or metastatic cervical cancer | ||
| 28.05. | Closing the last mile: translating national market access into real-world patient access in the UK | ||
| 27.05. | PMEA welcome Simon Bates as new Chair of the judging panel | ||
| 27.05. | Lilly to acquire LimmaTech Biologics and Vaccine Company in deals totalling $2.33bn | ||
| 26.05. | Where patient insight meets strategy: measuring what truly matters | ||
| 26.05. | GenAI is a new audience for medcomms: ensure your message is heard | ||
| 26.05. | From insight to interaction: how GenAI can strengthen engagement with healthcare professionals | ||
| 26.05. | Ramping up human-centricity in trial design | ||
| 26.05. | Lilly to acquire Curevo in deal worth $1.5bn | ||
| 26.05. | Moderna appoints Piyali Mukherjee as Head of Medical Affairs, Europe and Middle East | ||
| 22.05. | Cambridge Wide Open Week 2026 announces top-tier keynotes and participating ventures for new expanded format | ||
| 22.05. | One-carbon Therapeutics appoints Stefan Larsson and Raj Shah to Board of Directors | ||
| 21.05. | Multiple sclerosis patients and VML launch new brain-body rehabilitation technique | ||
| 21.05. | AstraZeneca's Baxfendy approved by US FDA for adults with uncontrolled hypertension | ||
| 21.05. | AMR Bio launches with phase 3-ready antimicrobial gel targeting surgical infections | ||
| 20.05. | Chiesi Group appoints Maria Paola Chiesi as New Chair | ||
| 20.05. | Bristol Myers Squibb announces strategic agreement with Anthropic | ||
| 19.05. | ZPB Associates appoints Rachel Allan as Managing Director | ||
| 19.05. | LEO Pharma and Allergy UK launch 'Don't Ignore' chronic hand eczema campaign | ||
| 18.05. | GSK signs agreement with Protas to streamline clinical trials | ||
| 18.05. | Regeneron agrees research collaboration with Parabilis Medicines |